AAAAAA
Results:
1-14
|
Results: 14
Authors:
KRISTENSEN JH
LLETT KF
DUSCI LJ
HACKETT LP
YAPP P
WOJNARHORTON RE
ROBERTS MJ
PAECH M
Citation: Jh. Kristensen et al., DISTRIBUTION AND EXCRETION OF SERTRALINE AND N-DESMETHYLSERTRALINE INHUMAN-MILK, British journal of clinical pharmacology, 45(5), 1998, pp. 453-457
Authors:
LLETT KF
HACKETT LP
DUSCI LJ
ROBERTS MJ
KRISTENSEN JH
PAECH M
GROVES A
YAPP P
Citation: Kf. Llett et al., DISTRIBUTION AND EXCRETION OF VENLAFAXINE AND O-DESMETHYLVENLAFAXINE IN HUMAN-MILK, British journal of clinical pharmacology, 45(5), 1998, pp. 459-462
Authors:
HACKETT LP
DUSCI LJ
ILETT KF
Citation: Lp. Hackett et al., A COMPARISON OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND FLUORESCENCE POLARIZATION IMMUNOASSAY FOR THERAPEUTIC DRUG-MONITORING OF TRICYCLIC ANTIDEPRESSANTS, Therapeutic drug monitoring, 20(1), 1998, pp. 30-34
Authors:
WOJNARHORTON RE
KRISTENSEN JH
YAPP P
ILETT KF
DUSCI LJ
HACKETT LP
Citation: Re. Wojnarhorton et al., METHADONE DISTRIBUTION AND EXCRETION INTO BREAST-MILK OF CLIENTS IN AMETHADONE-MAINTENANCE PROGRAM, British journal of clinical pharmacology, 44(6), 1997, pp. 543-547
Authors:
WOJNARHORTON RE
HACKETT LP
YAPP P
DUSCI LJ
PAECH M
ILETT KF
Citation: Re. Wojnarhorton et al., DISTRIBUTION AND EXCRETION OF SUMATRIPTAN IN HUMAN-MILK, British journal of clinical pharmacology, 41(3), 1996, pp. 217-221
Authors:
SACCOIA NC
HACKETT LP
MORRIS RG
ILETT KF
Citation: Nc. Saccoia et al., ENZYME-MULTIPLIED IMMUNOASSAY (EMIT-2000) DIGOXIN ASSAY COMPARED WITHFLUORESCENCE POLARIZATION IMMUNOASSAY AND AMERLEX I-125 RADIOIMMUNOASSAY AT 2 AUSTRALIAN CENTERS, Therapeutic drug monitoring, 18(6), 1996, pp. 672-677
Authors:
POWER BM
HACKETT LP
DUSCI LJ
ILETT KF
Citation: Bm. Power et al., ANTIDEPRESSANT TOXICITY AND THE NEED FOR IDENTIFICATION AND CONCENTRATION MONITORING IN OVERDOSE, Clinical pharmacokinetics, 29(3), 1995, pp. 154-171
Authors:
POWER BM
PINDER M
HACKETT LP
ILETT KF
Citation: Bm. Power et al., FATAL SEROTONIN SYNDROME FOLLOWING A COMBINED OVERDOSE OF MOCLOBEMIDE, CLOMIPRAMINE AND FLUOXETINE, Anaesthesia and intensive care, 23(4), 1995, pp. 499-502
Authors:
GOUCKE CR
HACKETT LP
ILETT KF
Citation: Cr. Goucke et al., CONCENTRATIONS OF MORPHINE, MORPHINE-6-GLUCURONIDE AND MORPHINE-3-GLUCURONIDE IN SERUM AND CEREBROSPINAL-FLUID FOLLOWING MORPHINE ADMINISTRATION TO PATIENTS WITH MORPHINE-RESISTANT PAIN, Pain, 56(2), 1994, pp. 145-149
Authors:
LEBEDEVS TH
WOJNARHORTON RE
YAPP P
ROBERTS MJ
DUSCI LJ
HACKETT LP
ILETT K
Citation: Th. Lebedevs et al., EXCRETION OF LIGNOCAINE AND ITS METABOLITE MONOETHYLGLYCINEXYLIDIDE IN BREAST-MILK FOLLOWING ITS USE IN A DENTAL PROCEDURE - A CASE-REPORT, Journal of clinical periodontology, 20(8), 1993, pp. 606-608
Authors:
ILETT KF
BLYTHE TH
HACKETT LP
ONG RTT
TANNENBAUM DA
CLARKE TMF
Citation: Kf. Ilett et al., PLASMA-CONCENTRATIONS OF DOTHIEPIN AND ITS METABOLITES ARE NOT CORRELATED WITH CLINICAL EFFICACY IN MAJOR DEPRESSIVE-ILLNESS, Therapeutic drug monitoring, 15(5), 1993, pp. 351-357
Authors:
BREHENY F
MCDONAGH T
HACKETT LP
ILETT KF
Citation: F. Breheny et al., DISPOSITION AND CLINICAL EFFECTS OF MORPHINE, MORPHINE-6-GLUCURONIDE AND MORPHINE-3-GLUCURONIDE FOLLOWING AN INTENTIONAL OVERDOSE OF SLOW-RELEASE ORAL MORPHINE IN A PATIENT WITH RENAL-FAILURE, Drug investigation, 6(5), 1993, pp. 291-295
Authors:
HACKETT LP
JOYCE DA
HALL RW
DUSCI LJ
ILETT KF
Citation: Lp. Hackett et al., DISPOSITION AND CLINICAL EFFECTS OF MOCLOBEMIDE AND 3 OF ITS METABOLITES FOLLOWING OVERDOSE, Drug investigation, 5(5), 1993, pp. 281-284
Authors:
SWENSEN G
ILETT KF
DUSCI LJ
HACKETT LP
ONG RTT
QUIGLEY AJ
LENTON S
SAKER R
CAPORN J
Citation: G. Swensen et al., PATTERNS OF DRUG-USE BY PARTICIPANTS IN THE WESTERN-AUSTRALIAN METHADONE PROGRAM, 1984-1991, Medical journal of Australia, 159(6), 1993, pp. 373-376
Risultati:
1-14
|